We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Tumor-Specific Imaging Agent Helps Resect Ovarian Cancer

By MedImaging International staff writers
Posted on 29 Jun 2016
Print article
Image: An intraoperative detection of ovarian cancer metastases using fluorescence-based imaging (Photo courtesy of LUMC).
Image: An intraoperative detection of ovarian cancer metastases using fluorescence-based imaging (Photo courtesy of LUMC).
A novel contrast agent for intraoperative near-infrared (NIR) fluorescence imaging can help surgeons detect nearly 30% more ovarian tumor tissue, according to a new study.

Developed by researchers at Leiden University Medical Center (LUMC, The Netherlands), the new, tumor-specific agent, called OTL38, is a combination of a NIR fluorescent dye and a folate analog. A dedicated imaging system is used to identify the fluorescent signal generated after the agent binds to a protein called folate receptor-alpha (FRα), which is expressed in more than 90% of ovarian cancers, but in much lower levels in healthy tissue. Since NIR light at 796 nm penetrates centimeters-deep into tissue, surgeons can use OTL38 to visualize tumors under the surface of the tissue.

In a randomized, double blind, placebo-controlled clinical trial, the researchers administered OTL38 to 12 patients who had epithelial ovarian cancer and were scheduled for cytoreductive surgery. They measured tolerability and blood pharmacokinetics, as well as the ability to detect the tumor. The results showed that OTL38 accumulated in both FR-α tumors and metastases, enabling the surgeons to resect an additional 29% of malignant lesions that were not identified using inspection or palpation. The study was published on June 15, 2106, in Clinical Cancer Research.

“Surgery is the most important treatment for ovarian cancer, and surgeons mainly have to rely on their naked eyes to identify tumor tissue, which is not optimal,” said lead author Alexander Vahrmeijer, MD, who heads the image-guided surgery group at LUMC. “A limitation of this study is that we cannot say yet what the impact of our findings is on cure or survival of the patients. It is reasonably plausible to assume that if more cancer is removed the survival will be better.”

Folate can be used like a Trojan horse to sneak an imaging agent or drug into a cancer cell; ovarian cancer has one of the highest rates of FR-α receptor expression. Approximately 80% of endometrial, lung, and kidney cancers, and 50% of breast and colon cancers also express the receptor.

Related Links:
Leiden University Medical Center

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Needle Guide
Ultra-Pro II
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
Compact C-Arm with FPD
Arcovis DRF-C R21

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.